Clinical Trial

Sodium Accumulation Study in Haemodialysis: Brain Study

Study acronym: SASH-B
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the research study is to look at a new type of MRI scanning that can measure the amount of sodium in different parts of the body. Sodium (or 'salt') levels are very important in maintaining health, and high levels lead to high blood pressure. This is very important to patients with kidney disease, as the kidney is the main organ that regulates the amount of sodium in the body. It is possible to measure blood sodium levels, but this does not tell us how much sodium is present in other areas of the body. Previously, it has not been possible measure this. Sodium MRI (Na-MRI) is a new type of MRI scanning that can directly measure sodium in other parts of body such as skin, muscles, kidneys, and brain. The investigators believe that this will help to guide treatment in patients with kidney disease who are on haemodialysis, research studies are needed to prove the benefits.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-21; most recent amendment 2024-08-07.
Status change: Not Yet Recruiting → Recruiting 2024-08-07
Trial Details
NCT Number NCT05966116
Lead Sponsor University Hospitals of Derby and Burton NHS Foundation Trust
Collaborators: University of Nottingham
Conditions Dialysis; Complications
Enrollment 10 participants
Start Date 2024-07-18
Primary Completion 2025-02 (estimated)
Study Completion 2025-02 (estimated)
Updated on ClinicalTrials.gov 2024-08-09